Peter Truesdell

1.0k total citations
23 papers, 802 citations indexed

About

Peter Truesdell is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Peter Truesdell has authored 23 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Peter Truesdell's work include Cell Adhesion Molecules Research (6 papers), Cellular Mechanics and Interactions (5 papers) and Cancer Cells and Metastasis (4 papers). Peter Truesdell is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Cellular Mechanics and Interactions (5 papers) and Cancer Cells and Metastasis (4 papers). Peter Truesdell collaborates with scholars based in Canada, United States and India. Peter Truesdell's co-authors include Andrew W. Craig, Jalna Meens, Kathleen Watt, Harish Chander, Peter A. Greer, Madhuri Koti, Charles H. Graham, Waheed Sangrar, Shannyn K. Macdonald-Goodfellow and Margaret G. Petroff and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Oncogene.

In The Last Decade

Peter Truesdell

23 papers receiving 795 citations

Peers

Peter Truesdell

ONCOL

IMMUN

Alessandra Magnifico Italy

Santiago Werbajh Argentina

Stacey C. Yang United States

Jorge Barbazán Spain

Liliana Guzman‐Rojas United States

Catherina L. Salanga United States

Paul A. Bromann United States

L. M. Gardner United States

Shannon P. Fortin Ensign United States

Kenji Nagao Japan

Alessandra Magnifico Italy

Peter Truesdell

621 ×1.7

384 ×1.1

ONCOL

163 ×0.9

IMMUN

108 ×0.8

130 ×0.9

Citations per year, relative to Peter Truesdell Peter Truesdell (= 1×) peers Alessandra Magnifico

Countries citing papers authored by Peter Truesdell

Since Specialization

Citations

This map shows the geographic impact of Peter Truesdell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Truesdell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Truesdell more than expected).

Fields of papers citing papers by Peter Truesdell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Truesdell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Truesdell. The network helps show where Peter Truesdell may publish in the future.

Co-authorship network of co-authors of Peter Truesdell

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Truesdell. A scholar is included among the top collaborators of Peter Truesdell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Truesdell. Peter Truesdell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Truesdell, Peter, Jessica Chang, Meiou Dai, et al.. (2024). Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes. npj Precision Oncology. 8(1). 186–186. 2 indexed citations

Newsted, Daniel, Kathleen Watt, Sarah Nersesian, et al.. (2018). Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models. OncoImmunology. 8(2). e1539613–e1539613. 36 indexed citations

Watt, Kathleen, Daniel Newsted, R. J. Gooding, et al.. (2018). MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma. Cellular Signalling. 50. 25–36. 23 indexed citations

Truesdell, Peter, et al.. (2017). Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Breast Cancer Research. 19(1). 110–110. 47 indexed citations

Peterson, Nichole, Peter Truesdell, Kasra Khalaj, et al.. (2017). CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer. Gynecologic Oncology. 145(3). 436–445. 38 indexed citations

Ling, Binbing, Kathleen Watt, Daniel Newsted, et al.. (2017). A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models. Oncotarget. 8(35). 58372–58385. 65 indexed citations

Minassian, Lori M., Shannyn K. Macdonald-Goodfellow, Peter Truesdell, et al.. (2017). Abstract 3960: Tumor cell drug resistance induced by the programmed death ligand 1 (PD-L1) immune checkpoint is associated with autophagy. Cancer Research. 77(13_Supplement). 3960–3960. 1 indexed citations

Watt, Kathleen, Peter Truesdell, Jalna Meens, et al.. (2015). Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis. Molecular Cancer Research. 13(6). 1044–1055. 19 indexed citations

Truesdell, Peter, Kathleen Watt, Jalna Meens, et al.. (2015). CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis. Oncotarget. 6(11). 9397–9408. 27 indexed citations

10.

Truesdell, Peter, Joseph Ahn, Harish Chander, et al.. (2014). CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis. Oncogene. 34(27). 3527–3535. 29 indexed citations

11.

Chander, Harish, Peter Truesdell, Kathleen Watt, et al.. (2014). Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis. Breast Cancer Research. 16(6). 3413–3413. 18 indexed citations

12.

Chander, Harish, et al.. (2014). Abstract 4053: Formin-binding protein-17 (FBP17) is a target of p53 and promotes invadopodia formation in breast cancer cells. Cancer Research. 74(19_Supplement). 4053–4053. 3 indexed citations

13.

Ahn, Joseph, Peter Truesdell, Jalna Meens, et al.. (2013). Fer Protein-Tyrosine Kinase Promotes Lung Adenocarcinoma Cell Invasion and Tumor Metastasis. Molecular Cancer Research. 11(8). 952–963. 44 indexed citations

14.

Chander, Harish, Peter Truesdell, Jalna Meens, & Andrew W. Craig. (2012). Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis. Oncogene. 32(25). 3080–3090. 38 indexed citations

15.

Hu, Jinghui, Peter Truesdell, Harish Chander, et al.. (2011). Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis. Journal of Cell Science. 124(10). 1739–1751. 43 indexed citations

16.

Arulanandam, Rozanne, Adina Vultur, Jun Cao, et al.. (2009). Cadherin-Cadherin Engagement Promotes Cell Survival via Rac1/Cdc42 and Signal Transducer and Activator of Transcription-3. Molecular Cancer Research. 7(8). 1310–1327. 43 indexed citations

17.

Truesdell, Peter, et al.. (2009). fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of E-cadherin-based adherens junctions in breast epithelial cells during lactation. Experimental Cell Research. 315(17). 2929–2940. 10 indexed citations

18.

Parsons, Sean A., Jeffrey Mewburn, Peter Truesdell, & Peter A. Greer. (2007). The Fps/Fes kinase regulates leucocyte recruitment and extravasation during inflammation. Immunology. 122(4). 542–550. 20 indexed citations

19.

Truesdell, Peter, Hiroshi Kataoka, Kuniaki Kojima, et al.. (2000). Molecular characterization of a cDNA from the true armyworm Pseudaletia unipuncta encoding Manduca sexta allatotropin peptide1Peptide designations have been assigned using the first three letters of the Genus name followed by the first two letters of the species name as proposed by the insect neuropeptide community attending the 19th Winter Neuropeptide Symposium, Breckenridge, CO, 1998. This change was proposed to ensure a unique organism abbreviation as the number of organisms from which peptides are purified increases and to conform with Swiss PRO. Thus Manse-AT is equivalent to the Manduca sexta allatotropin formerly abbreviated Mas-AT.1. Insect Biochemistry and Molecular Biology. 30(8-9). 691–702. 49 indexed citations

20.

Peteet, John R., et al.. (1992). Emotional support for patients with cancer who are undergoing CT: semistructured interviews of patients at a cancer institute.. Radiology. 182(1). 99–102. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact